![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Kleppner S.R. Tobin A.J.
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.5, Iss.2, 2001-04, pp. : 219-239
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel therapeutic targets for Huntington’s disease
Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neuroprotection in Huntington;s Disease
Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mitochondria: Prospective Targets for Neuroprotection in Parkinson’s Disease
Current Pharmaceutical Design, Vol. 20, Iss. 35, 2014-10 ,pp. :